Literature DB >> 3792385

Correlation between the saliva and free serum concentration of phenobarbital in epileptic children.

K Tokugawa, K Ueda, H Fujito, T Kurokawa.   

Abstract

Twenty epileptic children taking phenobarbital (PB) were evaluated for the concentration of PB in their saliva (Sa), total serum concentration (TS), free serum concentration (FS), and also the pH of the saliva samples. The Sa/TS ratio was 43.0 +/- 5.2% (mean +/- SD), and showed a close relationship between the two (r = 0.98). The free serum concentrations for PB were also observed to be closely correlated to the saliva concentration (r = 0.99), as well as to the total serum concentration, with the FS/TS ratio being 45.0 +/- 5.6%. However, no obvious relationship between the salivary pH and the Sa/TS ratio for PB was observed. This suggested the usefulness of monitoring the PB saliva concentrations in clinical management of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792385     DOI: 10.1007/bf00439247

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Use of saliva in monitoring carbamazepine medication in epileptic children.

Authors:  H Bartels; H D Oldigs; E Günther
Journal:  Eur J Pediatr       Date:  1977-08-23       Impact factor: 3.183

2.  Monitoring saliva anticonvulsant levels in children.

Authors:  G W Rylance
Journal:  Dev Med Child Neurol       Date:  1979-06       Impact factor: 5.449

Review 3.  Usefulness of blood levels of antiepileptic drugs.

Authors:  H Kutt; J K Penry
Journal:  Arch Neurol       Date:  1974-11

4.  Saliva and serum valproic acid levels in epileptic children.

Authors:  K Fung; K Ueda
Journal:  J Pediatr       Date:  1982-03       Impact factor: 4.406

5.  Pharmacologic advances in seizure control.

Authors:  M V Johnston; J M Freeman
Journal:  Pediatr Clin North Am       Date:  1981-02       Impact factor: 3.278

6.  Saliva carbamazepine and phenytoin level monitoring.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

7.  Rationale and clinical application of therapeutic drug monitoring.

Authors:  C E Pippenger
Journal:  Pediatr Clin North Am       Date:  1980-11       Impact factor: 3.278

8.  Saliva phenobarbital and phenytoin concentrations in epileptic adolescents.

Authors:  I M Friedman; I F Litt; R Henson; D Holtzman; D Halverson
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

9.  Salivary levels of anticonvulsants: a practical approach to drug monitoring.

Authors:  J J McAuliffe; A L Sherwin; I E Leppik; S A Fayle; C E Pippenger
Journal:  Neurology       Date:  1977-05       Impact factor: 9.910

  9 in total
  9 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Measurement of saliva tacrolimus levels in pediatric renal transplant recipients.

Authors:  Vladimir Belostotsky; Jo Adaway; Brian G Keevil; Dena R Cohen; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2010-10-24       Impact factor: 3.714

Review 3.  Feasibility of Using Oral Fluid for Therapeutic Drug Monitoring of Antiepileptic Drugs.

Authors:  Morgan Patrick; Samuel Parmiter; Sherif Hanafy Mahmoud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03       Impact factor: 2.441

4.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

Review 5.  Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.

Authors:  H Liu; M R Delgado
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 6.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

7.  Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia.

Authors:  Renée A Shellhaas; Chee M Ng; Christina H Dillon; John D E Barks; Varsha Bhatt-Mehta
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

8.  Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.

Authors:  Gilbert O Kokwaro; Bernhards R Ogutu; Simon N Muchohi; Godfrey O Otieno; Charles R J C Newton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.

Authors:  D Battino; M Estienne; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.